Is there an official KPV injection frequency?

No. KPV has no FDA-approved injectable label, so no regulatory body has set a required frequency. Figures that show up in research write-ups describe a specific protocol, not a fixed standard.

Does KPV injection frequency change the reconstitution math?

No. Frequency determines how many times a vial gets drawn from. Concentration is fixed the moment bacteriostatic water is added — vial mass divided by water volume — and stays constant regardless of how often a draw happens.

How do I work out how long a KPV vial lasts at a given frequency?

Divide the vial's total mcg by the target mcg dose to get doses per vial, then divide that by how often a draw happens. A 10 mg (10,000 mcg) vial dosed at 200 mcg holds 50 doses — 50 days at once daily, or 100 days at every other day.

Does a higher KPV injection frequency mean a smaller dose?

Not necessarily. Frequency and dose size are separate choices in a research protocol. A protocol can pair a higher frequency with a smaller per-draw dose, or hold the dose steady and simply draw the vial down faster.

KPV Injection Frequency Explained

By PeptCalc Research — Medically reviewed by David Mansour, MD — Last reviewed September 2, 2026

KPV injection frequency is not something a drug label specifies, because KPV has no FDA-approved injectable label to specify it. That puts it in a different position from an approved pharmaceutical, where frequency is fixed by regulatory review. This reference explains what actually determines frequency in KPV research protocols, and — more usefully — how frequency interacts with the reconstitution math that decides how long a vial actually lasts. It is written for research and educational purposes only and is not medical advice.

No approved label sets a fixed frequency

Some research peptides carry an approved formulation with a specific labeled schedule; tesamorelin, for example, has an approved once-daily label for its narrow indication, indexed on DailyMed (NIH/NLM). KPV does not have an equivalent approved injectable drug label. Without that regulatory anchor, there is no single "correct" KPV injection frequency the way there is for a handful of approved peptides — only frequencies that show up across different research write-ups, and those vary from source to source.

That absence of a fixed standard matches how KPV is treated elsewhere on this site: there's no single required water volume for reconstitution either, only reference concentrations chosen because they land common research doses on clean unit marks — see the KPV dosage chart. Frequency works the same way. It is a protocol detail set by whoever designed the specific research use, not a number handed down from an approved label.

What frequency actually controls

Frequency answers one question: how many times per period does a draw come out of the vial. It does not answer a separate question: what is the concentration of what's in the vial. That second question is fixed the moment bacteriostatic water is added:

Concentration = vial mass (mcg) ÷ water added (mL)

A vial reconstituted to a given concentration stays at that concentration through every draw, whether the schedule calls for one draw a day or one draw every few days. Frequency and concentration are independent variables that happen to combine into a third, more practical number: how many days a single vial will actually cover.

Worked example: vial life at two frequencies

Take a 10 mg KPV vial reconstituted with 2 mL of bacteriostatic water, at a 200 mcg target dose per draw — the same reference setup used in the KPV dosage chart.

Step 1 — convert vial mass to mcg. 10 mg = 10,000 mcg (1 mg = 1,000 mcg).

Step 2 — concentration. 10,000 mcg ÷ 2 mL = 5,000 mcg/mL.

Step 3 — volume per dose. 200 mcg ÷ 5,000 mcg/mL = 0.04 mL.

Step 4 — syringe units. On a U-100 insulin syringe, 1 mL = 100 units, so 0.04 mL × 100 = 4 units per draw.

Step 5 — doses per vial. 10,000 mcg ÷ 200 mcg = 50 doses. This number depends only on vial mass and dose size — the water volume chosen in Step 2 doesn't change it.

Step 6 — vial life by frequency. At once daily, 50 doses run 50 days, or about 7.1 weeks. At every other day, the same 50 doses stretch to 50 × 2 = 100 days, or about 14.3 weeks. Neither frequency is presented here as a recommendation — they're two illustrative points showing how the same vial and dose produce very different vial-life numbers depending on how often it's drawn.

A 5 mg vial at the same 200 mcg dose follows the identical formula at half the total. Reconstituted with 2 mL of water, it works out to 5,000 mcg ÷ 2 mL = 2,500 mcg/mL, which puts a 200 mcg draw at 0.08 mL, or 8 units — matching the KPV dosage chart. Doses per vial drop to 5,000 ÷ 200 = 25. At once daily that's 25 days (about 3.6 weeks); at every other day, 50 days (about 7.1 weeks).

Vial size	Concentration	Units per draw	Doses per vial	Vial life — once daily	Vial life — every other day
5 mg	2,500 mcg/mL	8 units	25	25 days (~3.6 weeks)	50 days (~7.1 weeks)
10 mg	5,000 mcg/mL	4 units	50	50 days (~7.1 weeks)	100 days (~14.3 weeks)

Frequency and dose size are separate decisions

It's easy to assume a higher KPV injection frequency automatically means a smaller per-draw dose, since that pattern shows up in some protocols. The arithmetic doesn't require it. A protocol can hold the dose steady and simply draw from the vial more often — which draws the vial down faster and shortens vial life — or it can lower the dose to stretch the same vial across more frequent draws. Frequency, dose size, and vial life are three separate numbers connected by the doses-per-vial formula above; changing one doesn't automatically change another unless the protocol is designed that way.

Why research protocols on frequency disagree

Because there's no approved label to converge around, published and self-reported KPV protocols describe a range of schedules rather than one standard. Some describe daily draws; others space them out further. KPV itself is a tripeptide corresponding to the C-terminal three residues of alpha-melanocyte-stimulating hormone, studied mainly in preclinical, gut-inflammation-focused research rather than controlled human trials — a thinner evidence base than better-studied research peptides, which is part of why protocol details like frequency vary so widely from one write-up to the next. This guide does not recommend a frequency or take a position on which protocol is better — that's a research design question outside the scope of a reconstitution reference. What the math above can tell you is how any given frequency plays out against a specific vial size, water volume, and dose once you've settled on one.

Keeping frequency and concentration from drifting apart

A frequency-based vial-life estimate is only accurate if the concentration behind it hasn't changed. Track the date a vial was reconstituted, not just when it was opened — see how to store reconstituted peptides for the general reasoning. If a vial that should supply 50 doses at 5,000 mcg/mL runs out sooner than the frequency and dose size predict, the concentration used in the original calculation is the more likely source of the mismatch, not the compound itself.

Common mistakes

Looking for an official KPV injection frequency. No approved label sets one — treat any specific number as a protocol detail, not a standard.
Assuming frequency changes concentration. It doesn't. Concentration is fixed at reconstitution; frequency only affects how fast the vial's total mcg gets drawn down.
Confusing mg and mcg when estimating vial life. KPV vials are labeled in milligrams, but research doses are typically described in micrograms — a 10 mg vial is 10,000 mcg, not 10.
Reusing a vial-life estimate after changing the water volume or dose. The 50-day and 100-day figures above only hold at 5,000 mcg/mL and a 200 mcg dose. Change either input and the vial-life number changes with it.

Use the calculator

Enter your KPV vial size, bacteriostatic water volume, and target dose into the peptide dosage calculator to get the exact concentration, draw volume, and syringe units, then apply your intended frequency to the doses-per-vial figure to estimate vial life. For the ratio side of the same math, see the KPV peptide reconstitution ratio guide.